✦ LIBER ✦

Relationship of mRNA expressions of RanBP2 and topoisomerase II isoforms to cytotoxicity of amrubicin in human lung cancer cell lines

✍ Scribed by Yoshitsugu Horio; Hirotaka Osada; Junichi Shimizu; Shizu Ogawa; Toyoaki Hida; Yoshitaka Sekido

Publisher: Springer
Year: 2009
Tongue: English
Weight: 424 KB
Volume: 66
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-1151-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of tumor necrosis factor, alone

Effects of tumor necrosis factor, alone or in combination with topoisomerase-ii-targeted drugs, on human lung cancer cell lines

✍ Giuseppe Giaccone; Chikabumi Kadoyama; Rhoda Maneckjee; David Venzon; Richard B. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 418 KB

## Abstract Tumor necrosis factor α (TNF) exhibits cytotoxic activity on some solid tumors and has been reported to be synergistic with topoisomerase‐II‐targeted antineoplastic agents. A wide range of TNF concentrations (from 10 to 10,000 U/ml) was tested in 9 human lung cancer cell lines (5 small‐

Comparison of dna cleavage induced by et

Comparison of dna cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase ii inhibitors

✍ Monica Binaschi; Giovanni Capranico; Paola De Isabella; Mariangela Mariani; Rosa 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 653 KB

Amplification of the topoisomerase ii α

Amplification of the topoisomerase ii α gene in a non-small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase ii α and β loci in normal tissue

✍ W. Nicol Keith; Robert Brown; K. B. Tan 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

n sylvan la (K. B.T.) DNA was prepared from normal tissue and I9 lung cancer cell lines. Using probes which detect restriction fragment length polymorphisms at both the topoisomerase II u and p loci, heterozygosity was detected at a frequency of 0. I 7 and 0.37 for the

Effects of wild-type p53 expression on t

Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIα and β in various human cancer cell lines

✍ Daniel Hochhauser; Nikola I. Valkov; Jana L. Gump; Irene Wei; Carolyn O'Hare; Jo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 1 views

The p53 null HL-60 cell line was transfected with plasmids coding for either the wild-type p53 or mutant p53 gene. The stable expression of wild-type p53 resulted in a significant increase in sensitivity to the topoisomerase II poisons etoposide and doxorubicin, but not to the topoisomerase II inhib

Cis-diamminedichloroplatinum(II) augment

Cis-diamminedichloroplatinum(II) augments expression of tumor-associated antigens on human gastric cancer cell line KATO-3 and increases susceptibility and binding of tumor cells to various cytotoxic effector cells

✍ Hayashi, Hitoshi; Nio, Yoshinori; Kawabata, Kazuya; Araya, Shinichi; Imamura, Ma 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 809 KB

Previous studies have demonstrated the immunomodulatory effects of cisplatin under certain conditions. The present study was designed to clarify whether cisplatin modulates the expression of surface antigens, especially human leukocyte antigen (HLA), on human tumor cell lines and/or augments the sus

CD80 expression in an HLA-A2-positive hu

CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer

✍ Dale L. Bixby; John R. Yannelli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix